INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)

$54.29 0 (0%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 71

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) News Sources

Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA

14-09-2026

yahoo.com

Altruist Biologics' Suzhou Site Receives EMA GMP Certification, Enabling Product Commercialization for the European Market

22-09-2026

yahoo.com

Innovent to Present New Clinical Data of Next-gen IO and ADC Pipeline at the 2026 ESMO Annual Meeting

23-09-2026

yahoo.com

Lilly’s latest China drug deal; Immunovant’s setback in lupus

24-09-2026

biopharmadive.com

Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC

28-09-2026

yahoo.com

Jaypirca® (pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) Across All Lines of Therapy

28-09-2026

yahoo.com

2026 IMS Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody IBI3003 (GPRC5D/BCMA/CD3) in Patients with Relapsed or Refractory Multiple Myeloma

29-09-2026

yahoo.com

Innovent Biologics (SEHK:1801) Stock Still Looks Below Fair Value As Shares Rose 153%

29-09-2026

yahoo.com

Top China Biopharma Stocks to Watch, According to Bernstein

30-09-2026

yahoo.com

Innovent Announces Phase 3 RESTORE-3 Study of SYCUME® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease

09-10-2026

yahoo.com

INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) Sentiment Trend

0 25 50 75 100 56 60 71 85 62 74 78 67 92 66 14-09-2026 22-09-2026 23-09-2026 24-09-2026 28-09-2026 29-09-2026 30-09-2026 09-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) FAQs

toggle

What is the current price of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?

The current price of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is $54.29.


toggle

INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) absolute price change since previous trading day?

The absolute price change of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) since the previous trading day is $0.


toggle

INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) percentage price change since previous trading day?

The percentage price change of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) since the previous trading day is 0%.


toggle

What is the most recent average sentiment score for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?

The most recent average sentiment score for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is 71 out of 100.


toggle

What is the most recent average sentiment for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?

The most recent sentiment for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is .


SEC-8K** Filing Available For INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.